Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

672 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of a topical formulation containing MIA (Melanoma Inhibitory Activity) - Inhibitory peptides in a case of recalcitrant vitiligo in combination with UV exposure.
Hernandez Navarro S, Segura Tejedor J, Bajona Roig M, Luisetto R, Fedrigo M, Castellani C, Angelini A, Alaibac M, Bordignon M. Hernandez Navarro S, et al. Among authors: angelini a. Medicine (Baltimore). 2022 Nov 18;101(46):e31833. doi: 10.1097/MD.0000000000031833. Medicine (Baltimore). 2022. PMID: 36401489 Free PMC article.
Coronary Collateral Circulation: A New Predictor of Mortality in Heart Transplant Recipients With Allograft Vasculopathy.
Civieri G, Masiero G, Osto E, Gambino A, Angelini A, Fraiese A, Fedrigo M, Toscano G, Bottio T, Perazzolo Marra M, Iliceto S, Gerosa G, Tona F. Civieri G, et al. Among authors: angelini a. Transplant Direct. 2023 Apr 19;9(5):e1470. doi: 10.1097/TXD.0000000000001470. eCollection 2023 May. Transplant Direct. 2023. PMID: 37090121 Free PMC article.
Human cytomegalovirus and Epstein-Barr virus infections occurring early after transplantation are risk factors for antibody-mediated rejection in heart transplant recipients.
Saldan A, Mengoli C, Sgarabotto D, Fedrigo M, Angelini A, Feltrin G, Gambino A, Gerosa G, Barzon L, Abate D. Saldan A, et al. Among authors: angelini a. Front Immunol. 2023 May 15;14:1171197. doi: 10.3389/fimmu.2023.1171197. eCollection 2023. Front Immunol. 2023. PMID: 37256129 Free PMC article.
MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation.
Schirone L, Vecchio D, Valenti V, Forte M, Relucenti M, Angelini A, Zaglia T, Schiavon S, D'Ambrosio L, Sarto G, Stanzione R, Mangione E, Miglietta S, Di Bona A, Fedrigo M, Ghigo A, Versaci F, Petrozza V, Marchitti S, Rubattu S, Volpe M, Sadoshima J, Frati L, Frati G, Sciarretta S. Schirone L, et al. Among authors: angelini a. Cell Mol Life Sci. 2023 Aug 11;80(9):245. doi: 10.1007/s00018-023-04877-7. Cell Mol Life Sci. 2023. PMID: 37566283 Free PMC article.
Report of the 2022 Banff Heart Concurrent: Focus on non-human leukocyte antigen antibodies in rejection and the pathology of "mixed" rejection.
Fedrigo M, Berry GJ, Coutance G, Reed EF, Lin CY, Giarraputo A, Kransdorf E, Thaunat O, Goddard M, Angelini A, Neil DAH, Bruneval P, Duong Van Huyen JP, Loupy A, Miller DV. Fedrigo M, et al. Among authors: angelini a. Am J Transplant. 2024 Apr;24(4):533-541. doi: 10.1016/j.ajt.2023.10.004. Epub 2023 Oct 12. Am J Transplant. 2024. PMID: 37838218 Free article.
When Waldenström macroglobulinemia hits the kidney: Description of a case series and management of a "rare in rare" scenario.
Danesin N, Scapinello G, Del Prete D, Naso E, Berno T, Visentin A, Bonaldi L, Martines A, Bertorelle R, Vianello F, Gurrieri C, Zambello R, Castellani C, Fedrigo M, Rizzo S, Angelini A, Trentin L, Piazza F. Danesin N, et al. Among authors: angelini a. Cancer Rep (Hoboken). 2024 Apr;7(4):e2062. doi: 10.1002/cnr2.2062. Cancer Rep (Hoboken). 2024. PMID: 38662353 Free PMC article.
672 results